• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

身体穿孔作为病毒性肝炎的一个风险因素:一项综合研究综述。

Body piercing as a risk factor for viral hepatitis: an integrative research review.

作者信息

Hayes M O, Harkness G A

机构信息

University of New Hampshire, School of Health and Human Services, Durham, USA.

出版信息

Am J Infect Control. 2001 Aug;29(4):271-4. doi: 10.1067/mic.2001.114402.

DOI:10.1067/mic.2001.114402
PMID:11486271
Abstract

The relationship of viral hepatitis and body piercing has been investigated in 12 research studies published between 1974 and 1997. Because there are often a large number of unknowns regarding the cause of viral hepatitis, most of the studies were conducted to identify multiple risk factors for hepatitis. Eight of the 12 studies identified percutaneous exposure, including body piercing and ear piercing, as a risk factor for viral hepatitis. Six studies found that hepatitis seropositivity was significantly associated with ear piercing. Conclusions indicate that evidence is sufficient to institute public health education along with regulation of the body-piercing industry. Recent research has found a significant increase in legislative efforts to regulate body piercing. Little research has focused directly on body piercing as a specific risk factor for viral hepatitis. Further research in this area is necessary to increase the understanding of hepatitis transmission by body piercing.

摘要

1974年至1997年间发表的12项研究对病毒性肝炎与身体穿刺之间的关系进行了调查。由于病毒性肝炎的病因往往存在大量未知因素,大多数研究旨在确定肝炎的多种风险因素。12项研究中有8项将经皮暴露(包括身体穿刺和耳垂穿刺)确定为病毒性肝炎的一个风险因素。6项研究发现肝炎血清阳性与耳垂穿刺显著相关。结论表明,有足够的证据开展公共卫生教育并对身体穿刺行业进行监管。最近的研究发现,规范身体穿刺的立法力度显著加大。很少有研究直接将身体穿刺作为病毒性肝炎的一个特定风险因素进行关注。有必要在这一领域开展进一步研究,以增进对通过身体穿刺传播肝炎的了解。

相似文献

1
Body piercing as a risk factor for viral hepatitis: an integrative research review.身体穿孔作为病毒性肝炎的一个风险因素:一项综合研究综述。
Am J Infect Control. 2001 Aug;29(4):271-4. doi: 10.1067/mic.2001.114402.
2
Risks associated with tattooing and body piercing.纹身和穿孔相关的风险。
J Public Health Policy. 1999;20(4):459-70.
3
Body piercing.身体穿孔。
School Nurse News. 2004 Jan;21(1):16-7.
4
Severe relapsing polychondritis occurring after ear piercing.穿耳洞后发生的严重复发性多软骨炎。
J Rheumatol. 2003 Dec;30(12):2716-7.
5
Patient information. Body piercing.
RN. 2004 Jun;67(6):49.
6
Body piercing: controlling the risk of infection.
Nurs Times. 2000;96(10 Suppl):8-9.
7
[Tattooing and body piercing--experiences from public health infection surveillance by a public health office].[纹身与身体穿刺——来自公共卫生办公室公共卫生感染监测的经验]
Gesundheitswesen. 2000 Apr;62(4):219-24. doi: 10.1055/s-2000-10860.
8
Prevalence of tattooing and body piercing in the Australian community.澳大利亚社区纹身与身体穿孔的流行情况。
Commun Dis Intell Q Rep. 2001 Apr;25(2):67-72. doi: 10.33321/cdi.2001.25.14.
9
Medical complications of modern art. What you need to know about body piercing.现代艺术的医学并发症。你需要了解的关于身体穿孔的知识。
Adv Nurse Pract. 2002 Jan;10(1):59-64.
10
An unusual complication of penile piercing: a report and literature review.
Br J Plast Surg. 2004 Jul;57(5):462-4. doi: 10.1016/j.bjps.2003.12.023.

引用本文的文献

1
Tattoos: risks and complications, clinical and histopathological approach.纹身:风险与并发症,临床与组织病理学方法。
An Bras Dermatol. 2024 Jul-Aug;99(4):491-502. doi: 10.1016/j.abd.2023.07.004. Epub 2024 Mar 22.
2
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program.卢旺达丙型肝炎病毒感染的危险因素:全国筛查计划的结果。
BMC Infect Dis. 2019 Aug 5;19(1):688. doi: 10.1186/s12879-019-4322-7.
3
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda.
卢旺达乙型肝炎表面抗原(HBsAg)阳性率及其相关因素分析。
BMC Infect Dis. 2019 May 3;19(1):381. doi: 10.1186/s12879-019-4013-4.
4
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.亚太肝脏研究学会关于丙型肝炎预防、流行病学及实验室检测的共识声明与建议
Hepatol Int. 2016 Sep;10(5):681-701. doi: 10.1007/s12072-016-9736-3. Epub 2016 May 26.
5
KASL clinical practice guidelines: management of hepatitis C.KASL临床实践指南:丙型肝炎的管理
Clin Mol Hepatol. 2016 Mar;22(1):76-139. doi: 10.3350/cmh.2016.22.1.76. Epub 2016 Mar 28.
6
APASL consensus statements and management algorithms for hepatitis C virus infection.亚太肝脏研究学会丙型肝炎病毒感染共识声明及管理算法
Hepatol Int. 2012 Apr;6(2):409-35. doi: 10.1007/s12072-012-9342-y. Epub 2012 Mar 1.
7
Iatrogenic patterned scar secondary to branding.烙印所致医源性花纹状瘢痕
Indian J Dermatol. 2014 Jul;59(4):424. doi: 10.4103/0019-5154.135549.
8
KASL clinical practice guidelines: management of hepatitis C.KASL临床实践指南:丙型肝炎的管理
Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30.
9
Piercing and tatooing in high school students of Veneto region: prevalence and perception of infectious releated risk.威尼托地区高中生的穿孔和纹身情况:患病率及对感染相关风险的认知
J Prev Med Hyg. 2013 Mar;54(1):17-23.
10
Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting.在基层医疗环境中,风险筛查器在识别丙型肝炎病毒方面的效果。
Am J Public Health. 2012 Nov;102(11):e115-21. doi: 10.2105/AJPH.2012.300659. Epub 2012 Sep 20.